Hanmi Science한미사이언스
008930 · KOSPI · ₩008930 · 한미사이언스
₩43,100▲ ₩900 (2.13%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩368B | ₩354B | ₩344B | ₩343B | ₩338B | ₩332B | ₩332B | ₩322B |
| Operating income | ₩59B | ₩34B | ₩38B | ₩39B | ₩35B | ₩27B | ₩13B | ₩22B |
| Net income | ₩1.4B | ₩42B | ₩86B | ₩3.6B | ₩3.9B | ₩24B | ₩39B | −₩3.1B |
| Net income to shareholders | ₩44B | ₩43B | ₩32B | ₩32B | ₩29B | ₩25B | −₩11B | ₩18B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩1.5T | ₩1.5T | ₩1.5T | ₩1.4T | ₩1.4T | ₩1.4T | ₩1.3T | ₩1.3T |
| Current assets | ₩377B | ₩392B | ₩426B | ₩349B | ₩332B | ₩333B | ₩328B | ₩287B |
| Cash and equivalents | ₩98B | ₩115B | ₩127B | ₩94B | ₩84B | ₩83B | ₩85B | ₩51B |
| Total liabilities | ₩472B | ₩495B | ₩530B | ₩524B | ₩511B | ₩516B | ₩510B | ₩462B |
| Current liabilities | ₩417B | ₩448B | ₩484B | ₩474B | ₩465B | ₩474B | ₩469B | ₩427B |
| Borrowings | ₩183B | ₩187B | ₩213B | ₩214B | ₩215B | ₩217B | ₩216B | ₩215B |
| Total equity | ₩1.1T | ₩1T | ₩959B | ₩922B | ₩870B | ₩847B | ₩839B | ₩839B |
| Shareholders' equity | ₩1.1T | ₩1T | ₩962B | ₩925B | ₩873B | ₩850B | ₩841B | ₩840B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩10B | ₩8B | ₩10B | ₩18B | ₩21B | −₩2B | ₩36B | ₩22B |
| Free cash flow | ₩10B | ₩8B | ₩10B | ₩18B | ₩21B | −₩2B | ₩36B | ₩22B |
| Dividends paid | ₩0 | ₩20B | ₩0 | ₩0 | ₩0 | ₩14B | ₩0 | ₩6.8B |
Consolidated where available. Amounts in won.
Also known as: Hanmi Science / 한미사이언스 / 008930 / KRX:008930
Source: KRX statistical information